These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23010350)

  • 1. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis.
    Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
    Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
    Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
    Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
    Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X
    Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.
    Xia W; Shi R; Zheng WL; Ma WL
    Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Three CTLA-4 Polymorphisms and Hashimoto's Thyroiditis Risk: An Updated Meta-Analysis with Trial Sequential Analysis.
    Hu Y; Xu K; Jiang L; Zhang L; Shi H; Cui D
    Genet Test Mol Biomarkers; 2018 Apr; 22(4):224-236. PubMed ID: 29461867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
    Gunesacar R; Erken E; Dinkci S
    Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between cytotoxic T-lymphocyte antigen-4 gene polymorphisms and lymphoid malignancy risk: evidence from a meta-analysis.
    Dai Z; Feng C; Zhang W; Liu J; Cao X; Zhang H; Liu Y; Wang M; Liu X; Dai Z
    Ann Hematol; 2016 Oct; 95(10):1685-94. PubMed ID: 27498821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.
    Sallakci N; Bacanli A; Coskun M; Yavuzer U; Alpsoy E; Yegin O
    Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 polymorphisms and susceptibility to Behcet's disease: a meta-analysis.
    Lee YH; Song GG
    Mol Biol Rep; 2012 Sep; 39(9):9041-5. PubMed ID: 22722994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
    Zhu CL; Huang Q; Liu CH; Xie F
    Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.
    Zhao JJ; Wang D; Yao H; Sun DW; Li HY
    World J Gastroenterol; 2015 Sep; 21(34):10025-40. PubMed ID: 26379408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
    Yi B; Pei Y; Wang C; Jiang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population.
    Du L; Yang J; Huang J; Ma Y; Wang H; Xiong T; Xiang Z; Zhang Y; Huang J
    BMC Med Genet; 2013 Apr; 14():46. PubMed ID: 23597029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
    Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
    Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association of CTLA-4 polymorphisms with susceptibility to Behçet disease.
    Du L; Yang P; Hou S; Zhou H; Kijlstra A
    Br J Ophthalmol; 2009 Oct; 93(10):1378-81. PubMed ID: 19570770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease.
    Gunesacar R; Erken E; Bozkurt B; Ozer HT; Dinkci S; Erken EG; Ozbalkan Z
    Int J Immunogenet; 2007 Feb; 34(1):45-9. PubMed ID: 17284227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of association between the +49A/G polymorphism of cytotoxic T-lymphocyte antigen-4 and thyroid associated ophthalmopathy.
    Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
    Curr Eye Res; 2015; 40(12):1195-203. PubMed ID: 25615025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.